PD-1 expression on tumor cells: a new target for cancer therapy

被引:0
|
作者
Tone, Mari [1 ,2 ]
Iwahori, Kota [1 ,2 ,3 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Resp Med & Clin Immunol, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Dept Clin Res Tumor Immunol, Osaka, Japan
[3] Osaka Univ, Grad Sch Med, Dept Clin Res Tumor Immunol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
关键词
Anti programmed death-1 antibody (anti-PD-1 antibody); cancer stemness; non-small cell lung cancer (NSCLC); chemoresistance; PATHWAYS;
D O I
10.21037/tlcr-23-683
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:186 / 189
页数:4
相关论文
共 50 条
  • [21] u Prognostic Significance of PD-1/PDL-1 Expression in Breast Cancer and Tumor Associated Immune Cells
    Li, Xin
    Leone, Jose P.
    Serdy, Kate
    Assylbekova, Binara
    Varma, Kavita R.
    Clark, Beth Z.
    Dabbs, David J.
    Bhargava, Rohit
    LABORATORY INVESTIGATION, 2017, 97 : 54A - 54A
  • [22] Revisiting PD-1 to target leukaemic stem cells
    Yang, Chong
    Suda, Toshio
    NATURE CELL BIOLOGY, 2023, 25 (01) : 17 - 19
  • [23] PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and target tumor cells within the tumor
    Ambler, Rachel
    Edmunds, Grace L.
    Tan, Sin Lih
    Cirillo, Silvia
    Pernes, Jane, I
    Ruan, Xiongtao
    Huete-Carrasco, Jorge
    Wong, Carissa C. W.
    Lu, Jiahe
    Ward, Juma
    Toti, Giulia
    Hedges, Alan J.
    Dovedi, Simon J.
    Murphy, Robert F.
    Morgan, David J.
    Wulfing, Christoph
    SCIENCE SIGNALING, 2020, 13 (649)
  • [24] Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy
    Wang, Xiaodong
    Yang, Xiaohui
    Zhang, Chang
    Wang, Yang
    Cheng, Tianyou
    Duan, Liqiang
    Tong, Zhou
    Tan, Shuguang
    Zhang, Hangjie
    Saw, Phei Er
    Gu, Yinmin
    Wang, Jinhua
    Zhang, Yibi
    Shang, Lina
    Liu, Yajuan
    Jiang, Siyuan
    Yan, Bingxue
    Li, Rong
    Yang, Yue
    Yu, Jie
    Chen, Yunzhao
    Gao, George Fu
    Ye, Qinong
    Gao, Shan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (12) : 6640 - 6650
  • [25] Combination Approaches to Target PD-1 Signaling in Cancer
    Moore, Emily K.
    Strazza, Marianne
    Mor, Adam
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [26] PD-1 AND PD-L1 EXPRESSION IN OVARIAN CANCER
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Fiegl, H.
    Marth, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 64 - 64
  • [27] PD-1 and PD-L1 expression in ovarian cancer
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Reimer, D.
    Zeimet, A.
    Fiegl, H.
    Marth, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [28] Targeting the PD-1 Pathway in Cancer Therapy
    Topalian, Suzanne L.
    ONCOLOGIST, 2012, 17 : 6 - 6
  • [29] CTHRC1 and PD-1/PD-L1 expression predicts tumor recurrence in prostate cancer
    Zhou, Qing
    Xiong, Wei
    Zhou, Xing
    Gao, Rui-Song
    Lin, Qun-Fang
    Liu, Hui-Ying
    Li, Juan-Ni
    Tian, Xue-Fei
    MOLECULAR MEDICINE REPORTS, 2019, 20 (05) : 4244 - 4252
  • [30] Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy
    Khatoon, Elina
    Parama, Dey
    Kumar, Aviral
    Alqahtani, Mohammed S.
    Abbas, Mohamed
    Girisa, Sosmitha
    Sethi, Gautam
    Kunnumakkara, Ajaikumar B.
    LIFE SCIENCES, 2022, 306